中國能源建設(03996.HK)附屬中標47億元中山市未達標水體綜合整治工程項目
格隆匯11月27日丨中國能源建設(03996.HK)宣佈,近日,公司附屬公司葛洲壩股份公司收到中標通知書,葛洲壩股份公司與北京首創股份有限公司、北京市市政工程設計研究總院有限公司、陝西工程勘察研究院有限公司組成的聯合體,中標中山市未達標水體綜合整治工程(五鄉、大南聯圍流域)EPC+O(勘察設計、採購、施工+運營)(第3次)項目。
該項目位於廣東省中山市,主要內容包括檢測與修改管道55.22公里,新建污水截污管總長542.35km,清淤5.22萬m3,河涌沿線生態修復工程、水務信息化建設工程等。該項目中標金額約為人民幣47億元,合作期限為96個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.